RXRX
Recursion Pharmaceuticals, Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $68M | +79.9% |
| Gross profit | $20M | −1.2% |
| Operating income | −$495M | — |
| Net income | −$476M | — |
| EPS | −$0.90 | — |
| Free cash flow | −$312M | — |
Recursion Pharmaceuticals, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $68M | +79.9% |
| Gross profit | $20M | −1.2% |
| Operating income | −$495M | — |
| Net income | −$476M | — |
| EPS | −$0.90 | — |
| Free cash flow | −$312M | — |